Riders · Health and Human Services Commission · Article II: Health and Human Services
Clear Process for Including Prescription Drugs on the Texas Drug Code Index
Rider 161 in the 2026-27 Act, page II-100
Through the session
- 2024-25 Act Not in this version
- Introduced (Senate) Not in this version
- Introduced (House) Not in this version
- Senate substitute New rider 135
- House substitute Unchanged rider 135
- House passed Unchanged rider 135
- Conference Unchanged rider 161
- 2026-27 Act Unchanged rider 161
Pick any two steps to compare their wording.
What changed in the text
Conference → 2026-27 Act: the same text in both versions.
Removed words are struck through; added words are underlined. Sources: Conference · 2026-27 Act.
Every version: numbers, statuses and source pages
| Version | Rider | Against the version before | Against the current budget | Source |
|---|---|---|---|---|
| 2024-25 ActGeneral Appropriations Act, 2024-25 Biennium | Not in this version | |||
| Introduced (Senate)Senate Bill 1 as introduced (LBB recommended, Senate) | Not in this version | |||
| Introduced (House)House Bill 1 as introduced (LBB recommended, House) | Not in this version | |||
| Senate substituteCommittee Substitute for Senate Bill 1 | 135 | New | Amended | Page II-92 |
| House substituteHouse Committee Substitute for Senate Bill 1 | 135 | Unchanged | Amended | Page II-89 |
| House passedSenate Bill 1 as passed the second house | 135 | Unchanged | Amended | Page II-89 |
| ConferenceConference Committee Report for Senate Bill 1 | 161 was 135 | Unchanged | Amended | Page II-100 |
| 2026-27 ActGeneral Appropriations Act, 2026-27 Biennium | 161 | Unchanged | Amended | Page II-100 |
Full text of each wording
Senate substitute, House substitute, House passed, Conference, 2026-27 Act
Source, page II-100Clear Process for Including Prescription Drugs on the Texas Drug Code Index. The Texas Health and Human Services Commission (HHSC) shall make clear their process for the inclusion of prescription drugs in the Medicaid and Children's Health Insurance Programs. In maintaining the prescription drug inclusion process, HHSC shall ensure that the timeline for review, including initiation of drug review, clinical evaluation, rate setting, Legislative Budget Board notification, and making the product available, does not extend past the 90th day of receipt of the completed application for coverage on the Texas Drug Code Index. After the applicable Drug Utilization Review Board meeting and approval by the HHSC Executive Commissioner, HHSC will complete the public posting of medical policies associated with the product.